“Obesity therapies have already taken cancer as the pharmaceutical industry's leading area of investment, reflecting growing confidence that these treatments could improve the health of millions of Americans while fundamentally reshaping one of the country's largest industries,”

John Teasley · said date not stated · reported 2026-08-20

John Teasley noted that obesity therapies have overtaken oncology as the leading investment area for the pharmaceutical industry.